Table 1

Use of antithrombotic drugs, beta-blockers and statins among men and women.



All three drugs
 Antithrombotics
 Betablockers
 Statins
 n


Men
 Women
 Men
 Women
 Men
 Women
 Men
 Women
 Men
 Women

Total
 51.6
 49.1
 93.3
 89.1
 81.8
 80.6
 62.1
 58.6
 1429
 1221
Age (years)
 45–54
 59.6
 45.2
 95.0
 85.0
 86.2
 77.4
 69.3
 52.7
 218
 93

55–64
 54.4
 46.0
 94.1
 87.6
 82.5
 79.8
 65.8
 55.0
 594
 411

65–74
 46.2
 51.3
 91.9
 90.5
 79.6
 81.5
 56.1
 61.4
 617
 717
Income third
 highest
 55.4
 48.0
 93.7
 89.4
 81.8
 80.3
 68.2
 55.1
 519
 303

intermed
 48.6
 51.9
 94.4
 89.0
 82.3
 81.7
 58.7
 61.9
 456
 366

lowest
 50.0
 50.1
 92.0
 89.0
 81.8
 80.9
 57.3
 60.1
 353
 468
MI
 no
 47.9
 47.1
 91.7
 87.5
 79.6
 79.2
 58.9
 56.7
 792
 916

yes
 55.3
 57.2
 95.5
 95.1
 85.1
 85.1
 64.5
 66.4
 613
 276
Use of
 less
 51.0
 48.4
 93.3
 89.1
 81.9
 81.0
 61.4
 57.8
 1211
 953
nitrates
 ≥ 1/week
 52.9
 53.4
 92.6
 90.2
 82.6
 79.4
 61.4
 62.5
 194
 246
Chest pain
 no
 51.8
 46.5
 94.1
 88.5
 80.0
 78.3
 63.6
 57.0
 738
 391

yes
 51.6
 50.8
 93.1
 89.6
 84.2
 81.7
 60.5
 60.1
 623
 758
Diabetes
 no
 51.3
 48.6
 92.9
 89.0
 81.1
 80.8
 61.9
 58.3
 1232
 1056

yes
 49.9
 54.2
 95.0
 91.0
 86.9
 81.1
 57.7
 62.9
 197
 165
Heart
 no
 51.7
 49.6
 93.4
 89.4
 82.0
 80.7
 62.4
 59.3
 1129
 962
failure
 yes
 48.9
 48.6
 92.3
 89.1
 81.5
 81.3
 57.3
 57.6
 300
 259
Revascularisation
 no
 41.7
 40.9
 90.5
 86.4
 80.3
 77.9
 51.4
 51.1
 738
 891

yes
 61.7
 72.9
 96.0
 97.2
 83.8
 88.4
 72.4
 80.4
 683
 322

Age group specific and age-standardised prevalence percentages by income, disease history and severity, and comorbidities.

Manderbacka et al. International Journal for Equity in Health 2008 7:16   doi:10.1186/1475-9276-7-16

Open Data